The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease

Saudi Medical Journal

Volumn 26, Issue 5, 2005, Pages 786-791

  Tuzcu, Alpaslan ^a   Bahceci, Mithat ^a   Yilmaz, Mehmet E ^a   Turgut, Cengiz ^a   Kara, Ismail H ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM ACETATE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; POTASSIUM ION; TRIACYLGLYCEROL; UREA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROLOGY; ORAL GLUCOSE TOLERANCE TEST; PARATHYROID HORMONE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); UNIVERSITY; UREA BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; TURKEY; UREMIA;

EID: 21344436640     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality inpatients with end-stage renal disease. J Am Soc Nephrol 2000; 13: 1894-1900.
2. De Fronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568.
3. Hager SR: Insulin resistance of uremia. Am J Kidney Dis 1989; 14: 272-276.
4. Rasic-Milutinovic Z, Perunicic-Pekovic G, Pljesa S. Clinical significance and pathogenic mechanisms of insulin resistance in chronic renal insufficiency (part II): pathogenic factors of insulin resistance in chronic renal insufficiency. Med Pregl 2000; 53: 159-163.
5. Mak RHK. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 2000; 54: 603-607.
6. Oshida Y, Sato Y, Shiraishi S, Sakamoto N. Studies on glucose intolerance in chronic renal failure: Estimation of insulin sensitivity before and after initiation of hemodialysis. Clin Nephrol 1987; 28:35-38.
7. Mak RHK. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 1996; 270: 839-894.
8. Mak RHK. 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41: 1048-1054.
9. Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant 1993; 8: 93-95.
10. Kokot F, Wiecek A, Grzeszczak W. Influence of erythropoietin treatment on endocrine abnormalities in hemodialyzed patients. In: Baldamus CA, Koch KM, Scigalla P, Wieczorek L, editors. Erythroprotein: From Molecular Structure to Clinical Application, Basel: Karger; 1990. p. 257-72.
11. Chagnac A, Korzets A, Zevin D, Korzets A, Hirsh J, Gafter U, et al. Effect of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994; 42: 398-400.
12. Allegra V, Mengozzi G, D'Achille F. Glucose-induced insulin secretion in uremia: role of anemia. Nephron 1992; 62: 246-247.
13. Yki-Jarvinen H, Glucose toxicity. Endocr Rev 1992; 13: 415-431.
14. National Kidney Foundation-Dialysis Outcomes Quality Initiative: Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997; 30 (Suppl 2): 70-73.
15. Matthews DR, Hosker JP, Rudenski AS, Burnett MA, Darling P, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
16. Turner RC, Holman RR, Matthews D. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979; 28: 1086-1096.
17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J physiol 1997; 237: 214-223.
18. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17: 152-154.
19. Beck-Nielsen H. Insulin resistance: Organ manifestations and cellular mechanisms. Ugeskr Laeger 2002; 164: 2130-2135
20. Delarue J, Maingourd C, Couet C, Vidal S, Begros P, Lamisse F. Effect of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects. Peritoneal Dial Int 1998; 18: 505-511.
21. Mak RHK. Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1995; 40: 304-308.
22. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 200 1; 17: 80-83.
23. Delarue J, Maingourd C. Acute metabolic effects of dialysis fluids during CAPD. Am J Kidney Dis 2001; 37: 103-107.
24. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 63: 425-435.